Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Experts are expecting strong results driven by the strong demand of Lilly's blockbuster medications, particularly its insulin portfolio. However, there are also concerns about potential headwinds from